<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03221998</url>
  </required_header>
  <id_info>
    <org_study_id>sor17ybyrctil</org_study_id>
    <nct_id>NCT03221998</nct_id>
  </id_info>
  <brief_title>The Effect of Timing of Intravenous Paracetamol Administration on Post-surgical Pain</brief_title>
  <official_title>The Effect of Timing of Intravenous Paracetamol Administration on Post-surgical Pain and Cytokines Levels Following Laparoscopic Sleeve Gastrectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Soroka University Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Soroka University Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is designed as a population-based prospective randomized cohort study. A
      prospective cohort of patients admitted to laparoscopic sleeve gastrectomy due to morbid
      obesity
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      All adult consecutive patients admitted to surgical departments for laparoscopic sleeve
      gastrectomy will be enrolled prospectively.

      For the purposes of the current study we want to determine how much paracetamol
      (acetaminophen) can reduce the cytokines levels in these patients

      The study enrollment period is planned to be a year. The follow-up period for each patient
      will be until discharge from the hospital.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">July 2017</start_date>
  <completion_date type="Anticipated">March 2020</completion_date>
  <primary_completion_date type="Anticipated">March 2019</primary_completion_date>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>This study is designed as a population-based prospective randomized cohort study. A prospective cohort of patients admitted to laparoscopic sleeve gastrectomy due to morbid obesity</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>measuring of Visual Analogue pain Scale,</measure>
    <time_frame>up to 48 hours after surgery</time_frame>
    <description>Visual Analogue pain Scale to determine patient level of pain , for establish the correct timing of paracetamol administration</description>
  </primary_outcome>
  <primary_outcome>
    <measure>measuring of Cytokine levels</measure>
    <time_frame>up to 48 hours after surgery</time_frame>
    <description>measuring of Cytokine levels in comparison of timing of paracetamol administration , as a predictor for inflammatory mediators released in response to noxious stimuli</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Total consumption of opiates after surgery</measure>
    <time_frame>up to 72 hours after surgery</time_frame>
    <description>post - operative opioid consumption in manner of dosage and frequency in ward</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Respiratory post-operative complication while in ward</measure>
    <time_frame>up to 72 hours after surgery</time_frame>
    <description>Respiratory complication (need of respiratory support, need of intensive care unit hospitalization)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>septic post-operative complication while in ward</measure>
    <time_frame>up to 72 hours after surgery</time_frame>
    <description>development of fever above 38° C</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiovascular post-operative complication while in ward</measure>
    <time_frame>up to 72 hours after surgery</time_frame>
    <description>Cardiovascular complication (hemodynamic instability, inotropic support )</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Gastrointestinal post-operative complication while in ward</measure>
    <time_frame>up to 72 hours after surgery</time_frame>
    <description>Gastrointestinal complaints as nausea and vomiting, need to use antiemetic drug</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>urinary trak post-operative complication while in ward</measure>
    <time_frame>up to 72 hours after surgery</time_frame>
    <description>Incidence of urinary retention and need for catheterization</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>post-operative pruritus while in ward</measure>
    <time_frame>up to 72 hours after surgery</time_frame>
    <description>Pruritus</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>post-operative hospitalization</measure>
    <time_frame>up to one week after surgery</time_frame>
    <description>length of hospital stay by number of days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Respiratory post-operative complication while recovering in post anesthesia care unit</measure>
    <time_frame>up to 5 hours after surgery</time_frame>
    <description>Respiratory complication need of respiratory support, need of intensive care unit hospitalization)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>septic post-operative complication while recovering in post anesthesia care unit</measure>
    <time_frame>up to 5 hours after surgery</time_frame>
    <description>Development of fever above 38° C</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiovascular post-operative complication while recovering in post anesthesia care unit</measure>
    <time_frame>up to 5 hours after surgery</time_frame>
    <description>Cardiovascular complication (hemodynamic instability, inotropic support )</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Gastrointestinal post-operative complication while recovering in post anesthesia care unit</measure>
    <time_frame>up to 5 hours after surgery</time_frame>
    <description>Gastrointestinal complication as nausea and vomiting, need to use antiemetic drugs</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>urinary retention post-operative complication while recovering in post anesthesia care unit</measure>
    <time_frame>up to 5 hours after surgery</time_frame>
    <description>incience of urinary retention and need for catheterization</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>post-operative pruritus while recovering in post anesthesia care unit</measure>
    <time_frame>up to 5 hours after surgery</time_frame>
    <description>Pruritus</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>post-operative stay in post anesthesia care unit</measure>
    <time_frame>up to 5 hours after surgery</time_frame>
    <description>length of post anesthesia care unit stay by number of hours</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">126</enrollment>
  <condition>Obesity, Morbid</condition>
  <arm_group>
    <arm_group_label>IV paracetamol</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients in the first group will receive in the operating room before surgery 1 gram (100 ml) of intravenous paracetamol ( IV paracetamol) for 15 minutes intraoperative</description>
  </arm_group>
  <arm_group>
    <arm_group_label>IV saline (NaCl 0.9 %)</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Patients in the second group will receive 100 mL NACL 0.9% (IV NaCl 0.9 %)intraoperative</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>IV paracetamol</intervention_name>
    <description>100 gram paracetamol infusion for moderate pain management</description>
    <arm_group_label>IV paracetamol</arm_group_label>
    <other_name>Perfalgan infusion (paracetamol)</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>IV saline (NaCl 0.9 %)</intervention_name>
    <description>100 ml of Normal Saline (IV NaCl 0.9 %) as placebo</description>
    <arm_group_label>IV saline (NaCl 0.9 %)</arm_group_label>
    <other_name>Normal Saline</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age ≥18 years

          -  Patients admitted for laparoscopic sleeve gastrectomy

          -  Elective surgery

          -  BMI &gt; 40

          -  American Society of Anesthesiology Classification: 1-2

        Exclusion Criteria:

          -  Patients' refusal to participate in the study

          -  Patients unable to give an informed consent

          -  Pregnancy

          -  Emergency surgery

          -  Patient with known allergy to paracetamol

          -  Patient with hepatic failure

          -  international normalized ratio &gt;1.7

          -  Albumin&lt;3.5g/Dl

          -  Bilirubin &gt;2mg/dL

          -  Patient with fever &gt; 37.5 ° C

          -  Patient with hemoglobin &lt; 8

          -  Patients chronically treated with steroids or steroid-treated patients over a month in
             the year preceding surgery.

        Drug addict
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael Semionov, MD</last_name>
    <role>Study Director</role>
    <affiliation>Soroka University Medical Center-Department of Anesthesiology</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Alexander Zlotnic, PhdMD</last_name>
    <role>Study Chair</role>
    <affiliation>Soroka University Medical Center-Department of Anesthesiology</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Yair Binyamin, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Soroka University Medical Center-Department of Anesthesiology</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Yair Yaish Reina, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Soroka University Medical Center-Department of Anesthesiology</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Yair Binyamin, MD</last_name>
    <phone>+972586963871</phone>
    <email>Yairben1@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Yair Yaish Reina, MD</last_name>
    <phone>+972545442655</phone>
    <email>yair0026@gmail.com</email>
  </overall_contact_backup>
  <reference>
    <citation>Ruiz-Tovar J, Muñoz JL, Gonzalez J, Zubiaga L, García A, Jimenez M, Ferrigni C, Durán M. Postoperative pain after laparoscopic sleeve gastrectomy: comparison of three analgesic schemes (isolated intravenous analgesia, epidural analgesia associated with intravenous analgesia and port-sites infiltration with bupivacaine associated with intravenous analgesia). Surg Endosc. 2017 Jan;31(1):231-236. doi: 10.1007/s00464-016-4961-3. Epub 2016 May 13.</citation>
    <PMID>27177956</PMID>
  </reference>
  <results_reference>
    <citation>Salihoglu T, Salihoglu Z, Zengin AK, Taskin M, Colakoglu N, Babazade R. The impacts of super obesity versus morbid obesity on respiratory mechanics and simple hemodynamic parameters during bariatric surgery. Obes Surg. 2013 Mar;23(3):379-83. doi: 10.1007/s11695-012-0783-0.</citation>
    <PMID>23054575</PMID>
  </results_reference>
  <results_reference>
    <citation>Rieg AD, Stoppe C, Rossaint R, Coburn M, Hein M, Schälte G. [EzPAP® therapy of postoperative hypoxemia in the recovery room : experiences with the new compact system of end-expiratory positive airway pressure]. Anaesthesist. 2012 Oct;61(10):867-74. doi: 10.1007/s00101-012-2083-4. Epub 2012 Sep 27. German.</citation>
    <PMID>23011043</PMID>
  </results_reference>
  <results_reference>
    <citation>Cullen A, Ferguson A. Perioperative management of the severely obese patient: a selective pathophysiological review. Can J Anaesth. 2012 Oct;59(10):974-96. Epub 2012 Jul 26. Review.</citation>
    <PMID>22833138</PMID>
  </results_reference>
  <results_reference>
    <citation>Aubrun F, Mazoit JX, Riou B. Postoperative intravenous morphine titration. Br J Anaesth. 2012 Feb;108(2):193-201. doi: 10.1093/bja/aer458. Review.</citation>
    <PMID>22250276</PMID>
  </results_reference>
  <results_reference>
    <citation>Macintyre PE, Loadsman JA, Scott DA. Opioids, ventilation and acute pain management. Anaesth Intensive Care. 2011 Jul;39(4):545-58. Review.</citation>
    <PMID>21823370</PMID>
  </results_reference>
  <results_reference>
    <citation>Schug SA, Raymann A. Postoperative pain management of the obese patient. Best Pract Res Clin Anaesthesiol. 2011 Mar;25(1):73-81. Review.</citation>
    <PMID>21516915</PMID>
  </results_reference>
  <results_reference>
    <citation>Daszkiewicz A, Wyleżoł M. Postoperative analgesia in a morbidly obese patient with chronic renal failure. Anestezjol Intens Ter. 2010 Oct-Dec;42(4):197-200.</citation>
    <PMID>21252836</PMID>
  </results_reference>
  <results_reference>
    <citation>Ahmed S, Morrow E, Morton J. Perioperative considerations when operating on the very obese: tricks of the trade. Minerva Chir. 2010 Dec;65(6):667-75.</citation>
    <PMID>21224800</PMID>
  </results_reference>
  <results_reference>
    <citation>Pelosi P, Gregoretti C. Perioperative management of obese patients. Best Pract Res Clin Anaesthesiol. 2010 Jun;24(2):211-25. Review.</citation>
    <PMID>20608558</PMID>
  </results_reference>
  <results_reference>
    <citation>Hans GA, Lauwick S, Kaba A, Brichant JF, Joris JL. Postoperative respiratory problems in morbidly obese patients. Acta Anaesthesiol Belg. 2009;60(3):169-75. Review.</citation>
    <PMID>19961114</PMID>
  </results_reference>
  <results_reference>
    <citation>Bodian CA, Freedman G, Hossain S, Eisenkraft JB, Beilin Y. The visual analog scale for pain: clinical significance in postoperative patients. Anesthesiology. 2001 Dec;95(6):1356-61.</citation>
    <PMID>11748392</PMID>
  </results_reference>
  <results_reference>
    <citation>Heinrich S, Horbach T, Salleck D, Birkholz T, Irouschek A, Schmidt J. [Perioperative anaesthesiological management in 167 patients undergoing bariatric surgery]. Zentralbl Chir. 2011 Dec;136(6):604-11. doi: 10.1055/s-0031-1271382. Epub 2011 Apr 14. German.</citation>
    <PMID>21495003</PMID>
  </results_reference>
  <verification_date>July 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 30, 2017</study_first_submitted>
  <study_first_submitted_qc>July 18, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">July 19, 2017</study_first_posted>
  <last_update_submitted>July 23, 2017</last_update_submitted>
  <last_update_submitted_qc>July 23, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">July 25, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Soroka University Medical Center</investigator_affiliation>
    <investigator_full_name>Yair Binyamin MD</investigator_full_name>
    <investigator_title>principal lnvestigator</investigator_title>
  </responsible_party>
  <keyword>morbidly obese</keyword>
  <keyword>,elective sleeve</keyword>
  <keyword>gastrectomy</keyword>
  <keyword>paracetamol</keyword>
  <keyword>IV Perfelgan</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Obesity, Morbid</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acetaminophen</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

